INDP INDAPTUS THERAPEUTICS INC Earnings Calls 8-K Filing 2024 - Research Presentation Indaptus Therapeutics, Inc. announced that Dr. Michael Newman will present new data on their research compound at a cancer research conference.Get access to all SEC 8-K filings of the INDAPTUS THERAPEUTICS INC